Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914890876> ?p ?o ?g. }
- W2914890876 endingPage "10" @default.
- W2914890876 startingPage "1" @default.
- W2914890876 abstract "The significance of uncommon EGFR mutations in newly diagnosed advanced non-small-cell lung cancer (NSCLC) patients is incompletely known. We aimed to analyze the demographic profile, outcome, and treatment attributes of these patients.We retrospectively surveyed 5,738 advanced NSCLC patients who underwent EGFR testing in our center from 2013 to 2017 by in-house primer probes on real time PCR platform. Descriptive data were accumulated from electronic medical records. Survival plot was calculated using Kaplan-Meier method and compared between groups using log-rank test.Out of 1,260 EGFR mutation-positive patients, 83 (6.58%) had uncommon mutations in isolation or in various combinations. Uncommon mutations were more frequent in men, never-smokers, and adenocarcinomas. Overall, exon 18 G719X, exon 20 insertion, exon 20 T790M, exon 20 S768I, and exon 21 (L858R/L861Q) were present in 9.6%, 19.3%, 12%, 3.6%, and 3.6% patients, respectively. Dual mutation positivity was found in 50.6% patients. On classifying patients as per tyrosine kinase inhibitor (TKI) sensitivity, it was found that majority of the patients had a combination TKI sensitive and insensitive mutations. The median duration of follow-up was 13 months. Five patients were lost to follow-up. Median progression-free survival on first line therapy was 6.7 months (95% CI: 4.8-8.5). Median overall survival (OS) of patients who received TKI during the course of their disease was 20.2 months (95% CI: 11.4-28.9). Median overall survival (mOS) of the entire cohort was 15.8 months (95% CI: 10.1-21.5). Among all uncommon mutations, patients with dual mutations did better, with an mOS time of 22.6 months (95% CI: 8.2-37.0, P=0.005). It was observed that TKI sensitive/TKI insensitive dual mutations had a superior OS of 28.2 months (95% CI: 15.2-41.2, P=0.039) as compared to TKI sensitive and TKI insensitive EGFR mutations.Uncommon EGFR mutations constitute a heterogeneous group, hence, it is imperative to understand each subgroup more to define optimal treatment." @default.
- W2914890876 created "2019-02-21" @default.
- W2914890876 creator A5003412464 @default.
- W2914890876 creator A5014835548 @default.
- W2914890876 creator A5024260749 @default.
- W2914890876 creator A5027531002 @default.
- W2914890876 creator A5031219890 @default.
- W2914890876 creator A5052732881 @default.
- W2914890876 creator A5058222441 @default.
- W2914890876 creator A5072262778 @default.
- W2914890876 creator A5088203043 @default.
- W2914890876 creator A5089917090 @default.
- W2914890876 date "2019-01-01" @default.
- W2914890876 modified "2023-10-13" @default.
- W2914890876 title "<p>Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis</p>" @default.
- W2914890876 cites W2001103672 @default.
- W2914890876 cites W2002937040 @default.
- W2914890876 cites W2005728761 @default.
- W2914890876 cites W2040299716 @default.
- W2914890876 cites W2111662961 @default.
- W2914890876 cites W2113521542 @default.
- W2914890876 cites W2139804581 @default.
- W2914890876 cites W2143138701 @default.
- W2914890876 cites W2154130790 @default.
- W2914890876 cites W2166084034 @default.
- W2914890876 cites W2608495247 @default.
- W2914890876 cites W2623290509 @default.
- W2914890876 cites W2768053061 @default.
- W2914890876 cites W2782686933 @default.
- W2914890876 cites W2791056050 @default.
- W2914890876 doi "https://doi.org/10.2147/lctt.s181406" @default.
- W2914890876 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6357894" @default.
- W2914890876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30774491" @default.
- W2914890876 hasPublicationYear "2019" @default.
- W2914890876 type Work @default.
- W2914890876 sameAs 2914890876 @default.
- W2914890876 citedByCount "22" @default.
- W2914890876 countsByYear W29148908762019 @default.
- W2914890876 countsByYear W29148908762020 @default.
- W2914890876 countsByYear W29148908762021 @default.
- W2914890876 countsByYear W29148908762022 @default.
- W2914890876 countsByYear W29148908762023 @default.
- W2914890876 crossrefType "journal-article" @default.
- W2914890876 hasAuthorship W2914890876A5003412464 @default.
- W2914890876 hasAuthorship W2914890876A5014835548 @default.
- W2914890876 hasAuthorship W2914890876A5024260749 @default.
- W2914890876 hasAuthorship W2914890876A5027531002 @default.
- W2914890876 hasAuthorship W2914890876A5031219890 @default.
- W2914890876 hasAuthorship W2914890876A5052732881 @default.
- W2914890876 hasAuthorship W2914890876A5058222441 @default.
- W2914890876 hasAuthorship W2914890876A5072262778 @default.
- W2914890876 hasAuthorship W2914890876A5088203043 @default.
- W2914890876 hasAuthorship W2914890876A5089917090 @default.
- W2914890876 hasBestOaLocation W29148908761 @default.
- W2914890876 hasConcept C104317684 @default.
- W2914890876 hasConcept C10515644 @default.
- W2914890876 hasConcept C121608353 @default.
- W2914890876 hasConcept C126322002 @default.
- W2914890876 hasConcept C143998085 @default.
- W2914890876 hasConcept C167135981 @default.
- W2914890876 hasConcept C2775999482 @default.
- W2914890876 hasConcept C2776256026 @default.
- W2914890876 hasConcept C2777930144 @default.
- W2914890876 hasConcept C2781182431 @default.
- W2914890876 hasConcept C36823959 @default.
- W2914890876 hasConcept C501734568 @default.
- W2914890876 hasConcept C54355233 @default.
- W2914890876 hasConcept C66339696 @default.
- W2914890876 hasConcept C71924100 @default.
- W2914890876 hasConcept C72563966 @default.
- W2914890876 hasConcept C86803240 @default.
- W2914890876 hasConcept C90924648 @default.
- W2914890876 hasConceptScore W2914890876C104317684 @default.
- W2914890876 hasConceptScore W2914890876C10515644 @default.
- W2914890876 hasConceptScore W2914890876C121608353 @default.
- W2914890876 hasConceptScore W2914890876C126322002 @default.
- W2914890876 hasConceptScore W2914890876C143998085 @default.
- W2914890876 hasConceptScore W2914890876C167135981 @default.
- W2914890876 hasConceptScore W2914890876C2775999482 @default.
- W2914890876 hasConceptScore W2914890876C2776256026 @default.
- W2914890876 hasConceptScore W2914890876C2777930144 @default.
- W2914890876 hasConceptScore W2914890876C2781182431 @default.
- W2914890876 hasConceptScore W2914890876C36823959 @default.
- W2914890876 hasConceptScore W2914890876C501734568 @default.
- W2914890876 hasConceptScore W2914890876C54355233 @default.
- W2914890876 hasConceptScore W2914890876C66339696 @default.
- W2914890876 hasConceptScore W2914890876C71924100 @default.
- W2914890876 hasConceptScore W2914890876C72563966 @default.
- W2914890876 hasConceptScore W2914890876C86803240 @default.
- W2914890876 hasConceptScore W2914890876C90924648 @default.
- W2914890876 hasLocation W29148908761 @default.
- W2914890876 hasLocation W29148908762 @default.
- W2914890876 hasLocation W29148908763 @default.
- W2914890876 hasLocation W29148908764 @default.
- W2914890876 hasOpenAccess W2914890876 @default.
- W2914890876 hasPrimaryLocation W29148908761 @default.
- W2914890876 hasRelatedWork W1593574816 @default.
- W2914890876 hasRelatedWork W19333003 @default.